TCIM
EIDX

TIAA CREF Investment Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

TIAA CREF Investment Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$715K Buy
+30,472
New +$489K ﹤0.01% 2459

Other funds holding EIDX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

TIAA CREF Investment Management's EIDX Position: Q1 2019 in Review

TIAA CREF Investment Management opened a new position in Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2019: 30,472 shares worth $715K. The stake represents ﹤0.01% of the portfolio and ranks #2459 among its holdings.

63 funds tracked by Wall St. Rank hold EIDX as of Q1 2019.

  • TIAA CREF Investment Management held 30,472 shares of Eidos Therapeutics, Inc. Common Stock worth $715K as of Q1 2019.
  • Eidos Therapeutics, Inc. Common Stock was a new TIAA CREF Investment Management position in Q1 2019.
  • Eidos Therapeutics, Inc. Common Stock made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2459 holding.
  • 63 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.